Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_Q9Y251-3_MUTAGEN_161_161.RASi3qFBZ_wgBMk4qK0Tk_3dEKWqF55ClJ_ptkJJ5VOZ8._1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_Q9Y251-3_MUTAGEN_161_161.RASi3qFBZ_wgBMk4qK0Tk_3dEKWqF55ClJ_ptkJJ5VOZ8._1 type RangedSequencePosition NX_Q9Y251-3_MUTAGEN_161_161.RASi3qFBZ_wgBMk4qK0Tk_3dEKWqF55ClJ_ptkJJ5VOZ8.assertion.
- NX_Q9Y251-3_MUTAGEN_161_161.RASi3qFBZ_wgBMk4qK0Tk_3dEKWqF55ClJ_ptkJJ5VOZ8._1 type SO_0001148 NX_Q9Y251-3_MUTAGEN_161_161.RASi3qFBZ_wgBMk4qK0Tk_3dEKWqF55ClJ_ptkJJ5VOZ8.assertion.
- NX_Q9Y251-3_MUTAGEN_161_161.RASi3qFBZ_wgBMk4qK0Tk_3dEKWqF55ClJ_ptkJJ5VOZ8._1 comment "Two-fold increase in the level of secretion upon addition of GS-modified heparin. No association with GS-modified heparin; when associated with K-161." NX_Q9Y251-3_MUTAGEN_161_161.RASi3qFBZ_wgBMk4qK0Tk_3dEKWqF55ClJ_ptkJJ5VOZ8.assertion.
- NX_Q9Y251-3_MUTAGEN_161_161.RASi3qFBZ_wgBMk4qK0Tk_3dEKWqF55ClJ_ptkJJ5VOZ8._1 SIO_000053 NX_Q9Y251-3_MUTAGEN_161_161.RASi3qFBZ_wgBMk4qK0Tk_3dEKWqF55ClJ_ptkJJ5VOZ8._2 NX_Q9Y251-3_MUTAGEN_161_161.RASi3qFBZ_wgBMk4qK0Tk_3dEKWqF55ClJ_ptkJJ5VOZ8.assertion.
- NX_Q9Y251-3_MUTAGEN_161_161.RASi3qFBZ_wgBMk4qK0Tk_3dEKWqF55ClJ_ptkJJ5VOZ8._1 SIO_000053 NX_Q9Y251-3_MUTAGEN_161_161.RASi3qFBZ_wgBMk4qK0Tk_3dEKWqF55ClJ_ptkJJ5VOZ8._3 NX_Q9Y251-3_MUTAGEN_161_161.RASi3qFBZ_wgBMk4qK0Tk_3dEKWqF55ClJ_ptkJJ5VOZ8.assertion.